SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001128732-16-000032
Filing Date
2016-11-07
Accepted
2016-11-07 12:10:17
Documents
1
Period of Report
2016-10-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3259
  Complete submission text file 0001128732-16-000032.txt   5053
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Issuer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 579 RUE LAJEUNESSE LAVAL A8 H7X 3K4
Business Address 579 RUE LAJEUNESSE LAVAL A8 H7X 3K4 514-949-6722
Advanomics Corp (Reporting) CIK: 0001681176 (see all company filings)

State of Incorp.: A8 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 000-52898 | Film No.: 161977189